Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients

TC Bruno, PJ Ebner, BL Moore, OG Squalls… - Cancer immunology …, 2017 - AACR
Effective immunotherapy options for patients with non–small cell lung cancer (NSCLC) are
becoming increasingly available. The immunotherapy focus has been on tumor-infiltrating T …
被引用次数：220 相关文章

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.

TC Bruno, PJ Ebner, BL Moore, OG Squalls… - Cancer Immunology …, 2017 - europepmc.org
Effective immunotherapy options for patients with non-small cell lung cancer (NSCLC) are
becoming increasingly available. The immunotherapy focus has been on tumor infiltrating T …

Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non–small cell lung cancer patients

TC Bruno, PJ Ebner, BL Moore, OG Squalls… - Cancer Immunology …, 2017 - elibrary.ru
We thank the University of Colorado Lung Cancer SPORE group for their help with patient
consent and tissue collection, especially Mary Jackson, Melissa Lemar, Heather Malinowski …

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients

TC Bruno, PJ Ebner, BL Moore… - Cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Effective immunotherapy options for patients with non-small cell lung cancer (NSCLC) are
becoming increasingly available. The immunotherapy focus has been on tumor-infiltrating T …
[HTML] nih.gov

[HTML][HTML] Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non-small cell lung cancer patients

TC Bruno, PJ Ebner, BL Moore… - Cancer immunology …, 2017 - ncbi.nlm.nih.gov
Effective immunotherapy options for patients with non-small cell lung cancer (NSCLC) are
becoming increasingly available. The immunotherapy focus has been on tumor infiltrating T …

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients

TC Bruno, PJ Ebner, BL Moore, OG Squalls… - Cancer Immunology …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Effective immunotherapy options for patients
with non–small cell lung cancer (NSCLC) are becoming increasingly available. The …
[PDF] researchgate.net

[PDF][PDF] Antigen-presenting intratumoral B cells affect CD4 TIL phenotypes in non-small cell lung cancer patients

TC Bruno, PJ Ebner, BL Moore, OG Squalls, KA Waugh… - researchgate.net
Effective immunotherapy options for patients with non-small cell lung cancer (NSCLC) are
becoming increasingly available. The immunotherapy focus has been on tumor infiltrating T …
[PDF] archive.org

[PDF][PDF] Antigen-Presenting Intratumoral B Cells Affect CD4 þ TIL Phenotypes in Non–Small Cell Lung Cancer Patients

TC Bruno, PJ Ebner, BL Moore, OG Squalls… - Cancer, 2017 - scholar.archive.org
Effective immunotherapy options for patients with non–small cell lung cancer (NSCLC) are
becoming increasingly available. The immunotherapy focus has been on tumorinfiltrating T …